Depression scores predict adherence in a dietary weight loss intervention trial
| Autor: | Shawn Somerset, Leanne Graham, Katherine Markwell |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Adult
Male medicine.medical_specialty food.ingredient Patient Dropouts Diet Reducing Saturated fat Overweight Motor Activity Critical Care and Intensive Care Medicine Macadamia nut law.invention Body Mass Index Fatty Acids Monounsaturated food Randomized controlled trial Weight loss law Weight management medicine Humans Nuts Aged Metabolic Syndrome Psychiatric Status Rating Scales Nutrition and Dietetics business.industry Depression Body Weight Beck Depression Inventory Middle Aged Macadamia Physical therapy Patient Compliance Female Queensland medicine.symptom business Dieting |
| Zdroj: | Clinical nutrition (Edinburgh, Scotland). 30(5) |
| ISSN: | 1532-1983 |
| Popis: | Depression has a complex association with cardiometabolic risk, both directly as an independent factor and indirectly through mediating effects on other risk factors such as BMI, diet, physical activity, and smoking. Since changes to many cardiometabolic risk factors involve behaviour change, the rise in depression prevalence as a major global health issue may present further challenges to long-term behaviour change to reduce such risk. This study investigated associations between depression scores and participation in a community-based weight management intervention trial.A group of 64 overweight (BMI 27), otherwise healthy adults, were recruited and randomised to follow either their usual diet, or an isocaloric diet in which saturated fat was replaced with monounsaturated fat (MUFA), to a target of 50% total fat, by adding macadamia nuts to the diet. Subjects were assessed for depressive symptoms at baseline and at ten weeks using the Beck Depression Inventory (BDI-II). Both control and intervention groups received advice on National Guidelines for Physical Activity and adhered to the same protocol for food diary completion and trial consultations. Anthropometric and clinical measurements (cholesterol, inflammatory mediators) also were taken at baseline and 10 weeks.During the recruitment phase, pre-existing diagnosed major depression was one of a range of reasons for initial exclusion of volunteers from the trial. Amongst enrolled participants, there was a significant correlation (R = -0.38, p 0.05) between BDI-II scores at baseline and duration of participation in the trial. Subjects with a baseline BDI ≥10 (moderate to severe depression symptoms) were more likely to dropout of the trial before week 10 (p 0.001). BDI-II scores in the intervention (MUFA) diet group decreased, but increased in the control group over the 10-week period. Univariate analysis of variance confirmed these observations (adjusted R(2) = 0.257, p = 0.01). Body weight remained static over the 10-week period in the intervention group, corresponding to a relative increase in the control group (adjusted R(2) = 0.097, p = 0.064).Depression symptoms have the potential to affect enrolment in and adherence to dietbased risk reduction interventions, and may consequently influence the generalisability of such trials. Depression scores may therefore be useful for characterising, screening and allocating subjects to appropriate treatment pathways. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect